MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Surgical outcomes in Rare Movement Disorders: A report of seventeen patients from India

    VV. Holla, D. Dhar, N. Kamble, R. Yadav, D. Srinivas, PK. Pal (Bengaluru, India)

    Objective: To study the outcome of functional neurosurgery among patients with Rare movement disorders (RMDs). Background: RMDs throw remarkable challenges to their appropriate management particularly…
  • 2022 International Congress

    Prevalence of Movement Disorders After Acute Stroke: a Large Prospective Cohort Stroke Study

    MS. Rocha, L. Alves, J. Tatsch, H. Bezerra, J. Freitas, I. Torres, J. de Paula, P. Marques, P. Matos (SAO PAULO, Brazil)

    Objective: To ascertain the prevalence of acute post-stroke movement disorders (PSMD) in a prospective cohort of acute stroke patients. Background: Post-stroke movement disorders can occur…
  • 2022 International Congress

    Network Fingerprint of Stimulation-Induced Speech Impairment in Parkinson’s Disease

    H. Jergas, JN. Petry-Schmelzer, JG. Hannemann, T. Thies, JC. Baldermann, JN. Strelow, HS. Dafsari, D. Muecke, V. Visser-Vandewalle, TA. Dembek, MT. Barbe (Cologne, Germany)

    Objective: To explore structural network correlates of stimulation-induced dysarthria (SID) in patients with Parkinson’s Disease (PD) chronically treated with deep brain stimulation (DBS) of the…
  • 2022 International Congress

    Safinamide adherence: the experience of the movement disorder unit of Trieste.

    M. Catalan, M. Liccari, V. Tommasini, L. Antonutti, P. Manganotti (Trieste, Italy)

    Objective: Describe the clinical experience with Safinamide and assess the patients’ adherence to this treatment in the movement disorders centre of Trieste-Italy. Background: Safinamide (Xadago®)…
  • 2022 International Congress

    EPIDEMIOLOGY OF FUNCTIONAL MOVEMENT DISORDERS

    B. Yardimci Kara, N. Oksuz Gurlen, O. Dogu (Mersin, Turkey)

    Objective: Our study aims to report the frequency of patients with FMD and to describe their demographic and clinical data. The second aim of our…
  • 2022 International Congress

    Single-cell characterization of patient midbrain tissue reveals tissue remodeling and glial activation in Parkinson’s disease

    S. Smajic, C. Prada-Medina, Z. Landoulsi, J. Ghelfi, S. Delcambre, C. Dietrich, J. Jarazo, J. Henck, S. Balachandran, S. Pachchek, C. Morris, P. Anotny, B. Timmermann, S. Sauer, S. Pereira, J. Schwamborn, P. May, M. Spielmann (Esch-sur-Alzette, Luxembourg)

    Objective: We aim to characterize the contribution of each midbrain cell type to PD pathology, and to identify cell types associated with genetic PD-risk variants.…
  • 2022 International Congress

    Hemichorea-hemiballismus following treatment of Intracranial tuberculomas and tuberculous meningitis

    A. Singh, N. Bansal, S. Shivangi, R. Gupta, J. Singhvi, J. Kaur (Mohali, India)

    Objective: To present a case of right-sided hemichorea-hemiballismus that occurred following treatment of intracranial tuberculomas and tuberculous meningitis Background: A 56-year-old lady presented in the…
  • 2022 International Congress

    Sigma Absolute Spectral Power is Associated with Depression in Parkinson’s Disease

    A. Memon, C. Catiul, Z. Irwin, J. Pilkington, A. Joop, R. Memon, K. Wood, G. Cutter, S. Miocinovic, A. Amara (Birmingham, USA)

    Objective: This cross-sectional study investigated the relationship between depression and sigma absolute spectral power (9-15 Hz) in the frequency range of sleep spindles during non-rapid…
  • 2022 International Congress

    Genome-wide association study of Aβ, t-tau and p-tau in CSF in Parkinson’s disease

    H. Iwaki (Bethesda, USA)

    Objective: To investigate genetic contributions to the Alzheimer’s disease (AD) related cerebrospinal fluid (CSF) biomarkers in the patients with Parkinson’s disease (PD). Background: Aβ, t-tau…
  • 2022 International Congress

    Multimodal assessment of nigrostriatal degeneration in de novo Parkinson’s disease

    M. López-Aguirre, M. Matarazzo, J. Blesa, A. Sánchez-Ferro, M. Hm Monje, J. Obeso, J. Pineda-Pardo (Móstoles, Spain)

    Objective: To study nigrostriatal changes with a multifactorial neuroimaging approach in order to further characterize early abnormalities in Parkinson’s Disease (PD). Background: Imaging techniques allow…
  • « Previous Page
  • 1
  • …
  • 399
  • 400
  • 401
  • 402
  • 403
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley